Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
VEGFD Biologics Sequence Review Report 2026: Vascular endothelial growth factor D Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of VEGFD protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FGF16 Biologics Sequence Review Report 2026: Fibroblast growth factor 16 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of FGF16 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FGF10 Biologics Sequence Review Report 2026: Fibroblast growth factor 10 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of FGF10 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCL16 Biologics Sequence Review Report 2026: C-C motif chemokine 16 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CCL16 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCL25 Biologics Sequence Review Report 2026: C-C motif chemokine 25 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CCL25 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
ACKR5 Biologics Sequence Review Report 2026: Atypical chemokine receptor 5 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of ACKR5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TNFSF11 Biologics Sequence Review Report 2026: Tumor necrosis factor ligand superfamily member 11 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of TNFSF11 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ACKR2 Biologics Sequence Review Report 2026: Atypical chemokine receptor 2 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of ACKR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCL21 Biologics Sequence Review Report 2026: C-C motif chemokine 21 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CCL21 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CXCR6 Biologics Sequence Review Report 2026: C-X-C chemokine receptor type 6 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CXCR6 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCL24 Biologics Sequence Review Report 2026: C-C motif chemokine 24 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CCL24 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR25 Biologics Sequence Review Report 2026: C-X-C chemokine receptor GPR25 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR25 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
198
199
200
201
202
>>
1503
>